Cancer Treatment Drugs - Global Top Players Market Share and Ranking 2026- YH Research

日本语 | 中文

Home > Reports >Pharma & Healthcare > Cancer Treatment Drugs - Global Top Players Market Share and Ranking 2026

Cancer Treatment Drugs - Global Top Players Market Share and Ranking 2026

Publication Date: 2026-01-05
Report Id: 2815692
Industry: Pharma & Healthcare
Report Page: 128
Chart: 123

PDF Download

Publication Date: 2026-01-05
Report Id: 2815692
Industry: Pharma & Healthcare
Report Page: 128
Chart: 123

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Cancer Treatment Drugs Definition
1.2 Global Cancer Treatment Drugs Market Size and Forecast
1.3 Japan Cancer Treatment Drugs Market Size and Forecast
1.4 Share of Japan Cancer Treatment Drugs Market with Respect to the Global Market
1.5 Cancer Treatment Drugs Market Size: Japan VS Global Growth Rate, 2021-2032
1.6 Cancer Treatment Drugs Market Dynamics
1.6.1 Cancer Treatment Drugs Market Drivers
1.6.2 Cancer Treatment Drugs Market Restraints
1.6.3 Cancer Treatment Drugs Industry Trends
1.6.4 Cancer Treatment Drugs Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Cancer Treatment Drugs, Global Market Share by Company, 2021-2026
2.2 Global Cancer Treatment Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Cancer Treatment Drugs Concentration Ratio
2.4 Global Cancer Treatment Drugs Mergers & Acquisitions, Expansion Plans
2.5 Global Cancer Treatment Drugs Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 Japan Leading Players, Market Share and Ranking
3.1 By Revenue of Cancer Treatment Drugs, Japan Market Share by Company, 2021-2026
3.2 Japan Cancer Treatment Drugs Cancer Treatment Drugs Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Cancer Treatment Drugs Industry Chain
4.2 Cancer Treatment Drugs Upstream Analysis
4.2.1 Cancer Treatment Drugs Core Raw Materials
4.2.2 Main Manufacturers of Cancer Treatment Drugs Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Cancer Treatment Drugs Production Mode
4.6 Cancer Treatment Drugs Procurement Model
4.7 Cancer Treatment Drugs Industry Sales Model and Sales Channels
4.7.1 Cancer Treatment Drugs Sales Model
4.7.2 Cancer Treatment Drugs Typical Distributors

5 Sights by Type
5.1 Cancer Treatment Drugs Classification by Type
5.1.1 Chemotherapy
5.1.2 Targeted Therapy
5.1.3 Immunotherapy
5.1.4 Others
5.2 by Type, Global Cancer Treatment Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
5.3 by Type, Global Cancer Treatment Drugs Consumption Value, 2021-2032

6 Sights by Application
6.1 Cancer Treatment Drugs Segment by Application
6.1.1 Lung Cancer
6.1.2 Breast Cancer
6.1.3 Prostate Cancer
6.1.4 Blood-related Cancer
6.1.5 Other
6.2 by Application, Global Cancer Treatment Drugs Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Application, Global Cancer Treatment Drugs Consumption Value, 2021-2032

7 Sales Sights by Region
7.1 By Region, Global Cancer Treatment Drugs Consumption Value, 2021 VS 2025 VS 2032
7.2 By Region, Global Cancer Treatment Drugs Consumption Value, 2021-2032
7.3 North America
7.3.1 North America Cancer Treatment Drugs Market Size & Forecasts, 2021-2032
7.3.2 By Country, North America Cancer Treatment Drugs Market Size Market Share
7.4 Europe
7.4.1 Europe Cancer Treatment Drugs Market Size & Forecasts, 2021-2032
7.4.2 By Country, Europe Cancer Treatment Drugs Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Cancer Treatment Drugs Market Size & Forecasts, 2021-2032
7.5.2 By Country/Region, Asia Pacific Cancer Treatment Drugs Market Size Market Share
7.6 South America
7.6.1 South AmericaCancer Treatment Drugs Market Size & Forecasts, 2021-2032
7.6.2 By Country, South America Cancer Treatment Drugs Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Cancer Treatment Drugs Market Size & CAGR, 2021 VS 2025 VS 2032
8.2 By Country, Global Cancer Treatment Drugs Consumption Value, 2021-2032
8.3 United States
8.3.1 United States Cancer Treatment Drugs Market Size, 2021-2032
8.3.2 by Type, United States Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.3.3 by Application, United States Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.4 Europe
8.4.1 Europe Cancer Treatment Drugs Market Size, 2021-2032
8.4.2 by Type, Europe Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.4.3 by Application, Europe Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.5 China
8.5.1 China Cancer Treatment Drugs Market Size, 2021-2032
8.5.2 by Type, China Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.5.3 by Application, China Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.6 Japan
8.6.1 Japan Cancer Treatment Drugs Market Size, 2021-2032
8.6.2 by Type, Japan Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.6.3 by Application, Japan Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.7 South Korea
8.7.1 South Korea Cancer Treatment Drugs Market Size, 2021-2032
8.7.2 by Type, South Korea Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.7.3 by Application, South Korea Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.8 Southeast Asia
8.8.1 Southeast Asia Cancer Treatment Drugs Market Size, 2021-2032
8.8.2 by Type, Southeast Asia Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.8.3 by Application, Southeast Asia Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.9 India
8.9.1 India Cancer Treatment Drugs Market Size, 2021-2032
8.9.2 by Type, India Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.9.3 by Application, India Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.10 Middle East & Africa
8.10.1 Middle East & Africa Cancer Treatment Drugs Market Size, 2021-2032
8.10.2 by Type, Middle East & Africa Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032
8.10.3 by Application, Middle East & Africa Cancer Treatment Drugs Consumption Value Market Share, 2025 VS 2032

9 Company Profile
9.1 Roche
9.1.1 Roche Company Information, Head Office, Market Area, and Industry Position
9.1.2 Roche Company Profile and Main Business
9.1.3 Roche Cancer Treatment Drugs Models, Specifications, and Application
9.1.4 Roche Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.1.5 Roche Recent Developments
9.2 Celgene
9.2.1 Celgene Company Information, Head Office, Market Area, and Industry Position
9.2.2 Celgene Company Profile and Main Business
9.2.3 Celgene Cancer Treatment Drugs Models, Specifications, and Application
9.2.4 Celgene Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.2.5 Celgene Recent Developments
9.3 Novartis
9.3.1 Novartis Company Information, Head Office, Market Area, and Industry Position
9.3.2 Novartis Company Profile and Main Business
9.3.3 Novartis Cancer Treatment Drugs Models, Specifications, and Application
9.3.4 Novartis Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.3.5 Novartis Recent Developments
9.4 Bristol-Myers Squibb
9.4.1 Bristol-Myers Squibb Company Information, Head Office, Market Area, and Industry Position
9.4.2 Bristol-Myers Squibb Company Profile and Main Business
9.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Models, Specifications, and Application
9.4.4 Bristol-Myers Squibb Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.4.5 Bristol-Myers Squibb Recent Developments
9.5 Johnson & Johnson
9.5.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
9.5.2 Johnson & Johnson Company Profile and Main Business
9.5.3 Johnson & Johnson Cancer Treatment Drugs Models, Specifications, and Application
9.5.4 Johnson & Johnson Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.5.5 Johnson & Johnson Recent Developments
9.6 Merck & Co.
9.6.1 Merck & Co. Company Information, Head Office, Market Area, and Industry Position
9.6.2 Merck & Co. Company Profile and Main Business
9.6.3 Merck & Co. Cancer Treatment Drugs Models, Specifications, and Application
9.6.4 Merck & Co. Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.6.5 Merck & Co. Recent Developments
9.7 AstraZeneca
9.7.1 AstraZeneca Company Information, Head Office, Market Area, and Industry Position
9.7.2 AstraZeneca Company Profile and Main Business
9.7.3 AstraZeneca Cancer Treatment Drugs Models, Specifications, and Application
9.7.4 AstraZeneca Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.7.5 AstraZeneca Recent Developments
9.8 Pfizer
9.8.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
9.8.2 Pfizer Company Profile and Main Business
9.8.3 Pfizer Cancer Treatment Drugs Models, Specifications, and Application
9.8.4 Pfizer Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.8.5 Pfizer Recent Developments
9.9 Amgen
9.9.1 Amgen Company Information, Head Office, Market Area, and Industry Position
9.9.2 Amgen Company Profile and Main Business
9.9.3 Amgen Cancer Treatment Drugs Models, Specifications, and Application
9.9.4 Amgen Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.9.5 Amgen Recent Developments
9.10 Eli Lilly
9.10.1 Eli Lilly Company Information, Head Office, Market Area, and Industry Position
9.10.2 Eli Lilly Company Profile and Main Business
9.10.3 Eli Lilly Cancer Treatment Drugs Models, Specifications, and Application
9.10.4 Eli Lilly Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.10.5 Eli Lilly Recent Developments
9.11 AbbVie
9.11.1 AbbVie Company Information, Head Office, Market Area, and Industry Position
9.11.2 AbbVie Company Profile and Main Business
9.11.3 AbbVie Cancer Treatment Drugs Models, Specifications, and Application
9.11.4 AbbVie Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.11.5 AbbVie Recent Developments
9.12 Takeda
9.12.1 Takeda Company Information, Head Office, Market Area, and Industry Position
9.12.2 Takeda Company Profile and Main Business
9.12.3 Takeda Cancer Treatment Drugs Models, Specifications, and Application
9.12.4 Takeda Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.12.5 Takeda Recent Developments
9.13 Astellas
9.13.1 Astellas Company Information, Head Office, Market Area, and Industry Position
9.13.2 Astellas Company Profile and Main Business
9.13.3 Astellas Cancer Treatment Drugs Models, Specifications, and Application
9.13.4 Astellas Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.13.5 Astellas Recent Developments
9.14 Ipsen
9.14.1 Ipsen Company Information, Head Office, Market Area, and Industry Position
9.14.2 Ipsen Company Profile and Main Business
9.14.3 Ipsen Cancer Treatment Drugs Models, Specifications, and Application
9.14.4 Ipsen Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.14.5 Ipsen Recent Developments
9.15 Sanofi
9.15.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
9.15.2 Sanofi Company Profile and Main Business
9.15.3 Sanofi Cancer Treatment Drugs Models, Specifications, and Application
9.15.4 Sanofi Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.15.5 Sanofi Recent Developments
9.16 Bayer
9.16.1 Bayer Company Information, Head Office, Market Area, and Industry Position
9.16.2 Bayer Company Profile and Main Business
9.16.3 Bayer Cancer Treatment Drugs Models, Specifications, and Application
9.16.4 Bayer Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.16.5 Bayer Recent Developments
9.17 Biogen Idec
9.17.1 Biogen Idec Company Information, Head Office, Market Area, and Industry Position
9.17.2 Biogen Idec Company Profile and Main Business
9.17.3 Biogen Idec Cancer Treatment Drugs Models, Specifications, and Application
9.17.4 Biogen Idec Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.17.5 Biogen Idec Recent Developments
9.18 Teva
9.18.1 Teva Company Information, Head Office, Market Area, and Industry Position
9.18.2 Teva Company Profile and Main Business
9.18.3 Teva Cancer Treatment Drugs Models, Specifications, and Application
9.18.4 Teva Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.18.5 Teva Recent Developments
9.19 Otsuka
9.19.1 Otsuka Company Information, Head Office, Market Area, and Industry Position
9.19.2 Otsuka Company Profile and Main Business
9.19.3 Otsuka Cancer Treatment Drugs Models, Specifications, and Application
9.19.4 Otsuka Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.19.5 Otsuka Recent Developments
9.20 Eisai
9.20.1 Eisai Company Information, Head Office, Market Area, and Industry Position
9.20.2 Eisai Company Profile and Main Business
9.20.3 Eisai Cancer Treatment Drugs Models, Specifications, and Application
9.20.4 Eisai Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.20.5 Eisai Recent Developments
9.21 Merck KGaA
9.21.1 Merck KGaA Company Information, Head Office, Market Area, and Industry Position
9.21.2 Merck KGaA Company Profile and Main Business
9.21.3 Merck KGaA Cancer Treatment Drugs Models, Specifications, and Application
9.21.4 Merck KGaA Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.21.5 Merck KGaA Recent Developments
9.22 Gilead Sciences
9.22.1 Gilead Sciences Company Information, Head Office, Market Area, and Industry Position
9.22.2 Gilead Sciences Company Profile and Main Business
9.22.3 Gilead Sciences Cancer Treatment Drugs Models, Specifications, and Application
9.22.4 Gilead Sciences Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.22.5 Gilead Sciences Recent Developments
9.23 Hengrui Medicine
9.23.1 Hengrui Medicine Company Information, Head Office, Market Area, and Industry Position
9.23.2 Hengrui Medicine Company Profile and Main Business
9.23.3 Hengrui Medicine Cancer Treatment Drugs Models, Specifications, and Application
9.23.4 Hengrui Medicine Cancer Treatment Drugs Revenue and Gross Margin, 2021-2026
9.23.5 Hengrui Medicine Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Cancer Treatment Drugs should grow from US$ 242670 million in 2025 to US$ 421630 million by 2032, with a CAGR of 8.3% for the period of 2026-2032.

Cancer Treatment Drugs are pharmaceutical substances used to treat various types of cancer by inhibiting the growth and spread of cancer cells. These drugs include chemotherapy agents, targeted therapies, immunotherapies, and hormone therapies, each working through different mechanisms to destroy or control malignant cells. With ongoing advancements in biomedical research, cancer treatment drugs are becoming more precise, aiming to improve survival rates and reduce side effects.

Cancer Treatment Drugs

According to YH Research, the global market for Cancer Treatment Drugs should grow from US$ 242670 million in 2025 to US$ 421630 million by 2032, with a CAGR of 8.3% for the period of 2026-2032.

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

The Cancer Treatment Drugs market is driven by the increasing global incidence of cancer and the growing demand for innovative and effective therapies. Advances in biotechnology have led to the development of targeted therapies, immunotherapies, and personalized medicine, significantly improving treatment outcomes and patient survival rates. Additionally, rising healthcare expenditure, especially in emerging economies, along with supportive government policies and funding for cancer research, further fuel market growth. The expansion of oncology drug pipelines by major pharmaceutical companies and the accelerated approval processes by regulatory bodies such as the FDA and EMA also contribute to the rapid introduction of new and advanced cancer treatment options.

Despite robust growth, the cancer treatment drugs market faces notable challenges, particularly the high cost of therapy, which limits accessibility for many patients, especially in low- and middle-income countries. The complex and lengthy drug development process, involving rigorous clinical trials and regulatory scrutiny, also poses a barrier for new entrants. Moreover, issues such as drug resistance, adverse side effects, and variability in patient response complicate treatment effectiveness. Intellectual property barriers and market exclusivity can further restrict the availability of affordable generics, impacting healthcare systems and patients alike. Addressing these challenges is essential for ensuring broader access to life-saving cancer therapies.

This report studies and analyses global Cancer Treatment Drugs status and future trends, to help determine the Cancer Treatment Drugs market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Cancer Treatment Drugs, and provides market size (US$ million) and Year-over-Year growth, considering 2025 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Cancer Treatment Drugs market size, history data 2021-2025, and forecast data 2026 -2032, (US$ million)
(2) Global Cancer Treatment Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(3) Japan Cancer Treatment Drugs by company, revenue, market share and industry ranking 2021-2026, (US$ million)
(4) Global Cancer Treatment Drugs key consuming regions, consumption value and demand structure
(5) Cancer Treatment Drugs industry chains, upstream, midstream and downstream
Market segment by players, this report covers
    Roche
    Celgene
    Novartis
    Bristol-Myers Squibb
    Johnson & Johnson
    Merck & Co.
    AstraZeneca
    Pfizer
    Amgen
    Eli Lilly
    AbbVie
    Takeda
    Astellas
    Ipsen
    Sanofi
    Bayer
    Biogen Idec
    Teva
    Otsuka
    Eisai
    Merck KGaA
    Gilead Sciences
    Hengrui Medicine

Market segment by Type, covers
    Chemotherapy
    Targeted Therapy
    Immunotherapy
    Others

Market segment by Application, can be divided into
    Lung Cancer
    Breast Cancer
    Prostate Cancer
    Blood-related Cancer
    Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Cancer Treatment Drugs product scope, global consumption value, Japan consumption value, development opportunities, challenges, trends, and policies
Chapter 2: Global Cancer Treatment Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 3: Japan Cancer Treatment Drugs market share and ranking of major manufacturers, revenue, 2021-2026
Chapter 4: Cancer Treatment Drugs industry chain, upstream, medium-stream, and downstream
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2021-2032
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2021-2032
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin
Chapter 10: Conclusions